Compound Summary
IMAZODAN
Compound Information
IMAZODAN
Compound Name: | IMAZODAN |
Compound CID: | 55918 |
Synonyms: | IMAZODAN 84243-58-3 6-(4-(1H-imidazol-1-yl)phenyl)-4,5-dihydropyridazin-3(2H)-one UNII-6PVQ5VQW24 CI 914 More... |
Iupac Name: | 3-(4-imidazol-1-ylphenyl)-4,5-dihydro-1H-pyridazin-6-one |
InChI: | InChI=1S/C13H12N4O/c18-13-6-5-12(15-16-13)10-1-3-11(4-2-10)17-8-7-14-9-17/h1-4,7-9H,5-6H2,(H,16,18) |
InChIKey: | VXMYWVMXSWJFCV-UHFFFAOYSA-N |
Canonical Smiles: | C1CC(=O)NN=C1C2=CC=C(C=C2)N3C=CN=C3 |
Isomeric Smiles: | C1CC(=O)NN=C1C2=CC=C(C=C2)N3C=CN=C3 |
Molecular Weight: | 240.26 |
Molecular Formula: | C13H12N4O |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
IMAZODAN
Molecular Weight: | 240.26 |
Molecular Formula: | C13H12N4O |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 2 |
Heavy Atom Count: | 18 |
Complexity: | 347 |
Synonyms
IMAZODAN
| IMAZODAN | IMAZODAN |
|---|---|
IMAZODAN |
84243-58-3 |
6-(4-(1H-imidazol-1-yl)phenyl)-4,5-dihydropyridazin-3(2H)-one |
UNII-6PVQ5VQW24 |
CI 914 |
Cl 914 |
3-(4-imidazol-1-ylphenyl)-4,5-dihydro-1H-pyridazin-6-one |
6PVQ5VQW24 |
CHEMBL12831 |
MFCD00867109 |
NCGC00015547-02 |
4,5-Dihydro-6-4-(1H-imidazol-1-yl)phenyl-3(2H)-pyridazinone |
3(2H)-Pyridazinone, 4,5-dihydro-6-4-(1H-imidazol-1-yl)phenyl- |
Imazodan INN |
Imazodanum Latin |
Imazodanum |
3(2H)-Pyridazinone, 4,5-dihydro-6-(4-(1H-imidazol-1-yl)phenyl)- |
Lopac-I-0782 |
DSSTox_CID_25160 |
DSSTox_RID_80710 |
DSSTox_GSID_45160 |
Lopac0_000639 |
MLS000862182 |
SCHEMBL148436 |
ZINC1553 |
Imazodan, >=99% (HPLC) |
DTXSID1045160 |
HMS2233L24 |
HMS3261P20 |
HMS3369I22 |
Tox21_110171 |
Tox21_500639 |
BDBM50000315 |
AKOS027327583 |
CCG-204726 |
LP00639 |
QC-1573 |
SDCCGSBI-0050619.P002 |
NCGC00015547-01 |
NCGC00015547-03 |
NCGC00015547-04 |
NCGC00015547-05 |
NCGC00094006-01 |
NCGC00094006-02 |
NCGC00261324-01 |
DS-11856 |
K504 |
SMR000326945 |
CAS-84243-58-3 |
DB-056777 |
EU-0100639 |
FT-0630925 |
I 0782 |
4,5-dihydro-6-4-(1H-imidazol-1-yl)phenyl- |
A923273 |
SR-01000075931 |
SR-01000075931-1 |
Q27265291 |
6-(4-Imidazol-1-yl-phenyl)-4,5-dihydro-2H-pyridazin-3-one |
(CI-914)6-(4-Imidazol-1-yl-phenyl)-4,5-dihydro-2H-pyridazin-3-one |
6-(4-Imidazol-1-yl-phenyl)-4,5-dihydro-2H-pyridazin-3-one(CI-914) |
6-(4-Imidazol-1-yl-phenyl)-4,5-dihydro-2H-pyridazin-3-one(Imazodan) |
Experimental Data
IMAZODAN
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | -2.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
IMAZODAN
Statistics Data
IMAZODAN
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -2.000000000000000 | 1 | 1 |
Statistics Data Visualization
IMAZODAN
